Effect of in vitro synergy and additivity of vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus bacteraemia on mortality: preplanned analysis from CAMERA2

Clinical Microbiology and Infection 2026

View at publisher
Authors: J. Soo, Tze-Peng Lim, Jayden J.Y. Ho, Steven Y.C. Tong, David C. Lye, Joshua S. Davis, Andrea L.H. Kwa, Dafna Yahav, Archana Sud, J.Owen Robinson, Jane Nelson, Sophia Archuleta
+35 more Matthew A. Roberts, Alan Cass, David L. Paterson, Hong Foo, Mical Paul, Stephen Guy, Adrian R. Tramontana, Genevieve B Walls, Stephen McBride, Narin Bak, Niladri Ghosh, Benjamin A. Rogers, Anna P. Ralph, Jane Davies, Patricia E. Ferguson, Ravindra Dotel, Genevieve L. McKew, Timothy Gray, Natasha E. Holmes, E. Suzanne Smith, Morgyn S. Warner, Shirin Kalimuddin, Barnaby E. Young, Naomi Runnegar, David Andresen, Nicholas A. Anagnostou, Sandra A. Johnson, Mark D. Chatfield, Allen C. Cheng, Vance G. Fowler, Benjamin P. Howden, Niamh Meagher, David J. Price, Sebastiaan J. van Hal, Matthew V.N.O Sullivan
DOI: 10.1016/j.cmi.2026.01.032
Cited by: 2
References: 19

Fields of Study & Subjects

Antimicrobial Resistance in Staphylococcus Antibiotic Use and Resistance Antibiotics Pharmacokinetics and Efficacy

Publication details

Journal / source
Clinical Microbiology and Infection
Publisher
Elsevier BV
Volume
32
Issue
5
Pages
829–837
Publication date
10 February 2026
Language
EN